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Mapping Health Care Innovation: 
 Tracing Walls & Ceilings 
by 
Friso den Hertog, Marjan Groen and Rifka Weehuizen 
April 1, 2005  
MERIT/University Maastricht 
 
 
 
Abstract 
 
Health care is in need of innovation on many strands. Patient-centered care appears to be the 
key to the realization of the main objectives: service quality, cost reduction, access, patient 
satisfaction and the quality of working life. Innovation, and more precisely, the diffusion and 
implementation of new methods, new techniques and new processes and systems appears to 
be a difficult task. Consequently, there is a strong need for knowledge about innovation 
processes in health care and the drivers and barriers affecting these efforts. This paper 
presents a framework for mapping innovation processes in health care services. The 
framework consists of two axes: (1) the horizontal axis of the health care process and the 
inter-functional walls which can complicate innovation efforts, and (2) the vertical axis of the 
echelons of power, which often create ceilings too impermeable to permit effective learning 
and decision making. The study is based on the experiences gathered in Publin, a running 
research network supported by the Fifth Framework Program and Innoflex, which ended in 
2003.  
 
JEL codes: I11, O31 (Analysis of Health Care Markets, Innovation and Invention: Processes 
and Incentives) 
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1. Introduction 
 
There is an urgent need for innovation in health care. That call is heard in almost any 
developed and less developed country. A recent OECD study (Docteur and Oxley 2003) 
indicates that costs have reached an all times high. Cost control measures in the 1980s and 
1990s appear not to have addressed the root causes of the growth of health care spending. It is 
remarkable in this respect that the rising costs of modern technology and new drugs are 
regarded (Docteur and Oxley 2003) as cost drivers rather than cost reducers. At the same time 
a number of OECD countries are concerned that care spending restrictions have gone too far 
and hurt health care performance. The quality of health care is the second strand where 
reforms appear to be needed. Waiting lists are a well-known phenomenon in many countries. 
Safety is an issue that cannot be regarded as self-evident. Studies (Kohn et al. 2000) based on 
information derived from root-cause analysis of specific incidents suggest that poor design of 
health care delivery systems, rather than technical incompetence among individual 
professionals underlies the majority of the problems. Surveys within five OECD-countries  
(Blendon et al. 2002, p. 189) show that many health care consumers are dissatisfied with their 
health care system and a vast majority of these consumers indicates that “fundamental 
changes” are needed, or that the system has to be rebuilt completely. Dissatisfaction is also 
widespread under the care providing professionals themselves. Job dissatisfaction is a major 
reason for physicians to withdraw from practice (Burke 2003), and restructuring of care 
services, mostly resulting in the increase of the patient-to-nurse ratio has a strong negative 
impact on the satisfaction among nursing staff (Williams et al. 2001). Finally, even in 
countries, where universal insurance coverage is regarded as a political norm barriers for 
access to health services appear to rise, both with regard to specific under-privileged groups 
and in terms of restrictions of specific risks in the healthcare policies (Docteur and Oxley 
2003).  
 
Debates about innovation are taking place at almost any level of the health system: 
from the hospital floor, to the management- ranks and the level of the policy-makers. In these 
discussions, there is one basic hope. That hope is, that the problem areas mentioned above are 
not fundamentally a set of contradictory demands. That means that improvements in the 
efficiency of the system are not by definition an infringement on quality of care, and that 
quality improvements are imaginable without spending extra money. The hope is that the 
improvement of the quality of care is the key to controlling the cost of the care. In this way 
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effective treatment results in higher satisfaction of patients, nurses and doctors, faster 
recovery and better final outcomes, and as a result: in lower costs. Most advocates of this 
logic take a patient-centered view on the changes needed in the health service, meaning that  
patient care should be redesigned so that health care resources are organized around patients 
rather than around various specialized departments or functions of care providing systems 
(Sherer 1993, p.14). This perspective has inspired health professionals, managers and 
politicians in many countries. There is a wide variety of developmental, or experimental 
projects throughout the OECD-countries, both on the higher system level, as on the 
management and operational level of health care. Especially the many experiments at the 
service level of health care show that health care can be made more effective, safe, patient-
friendly, faster and more efficient (Schrijvers et al. 2002). However, studies like these also 
show, that innovation in health care is a difficult process.  
 
The implementation and diffusion of new solutions, rather than their invention, seems 
to be the vulnerable phase of the innovation (Adler et al. 2003, Denis et al. 2002, Schrijvers et 
al. 2002).  Sackett et al.(1997, p.7) point out that present medical practice has a firm base in 
scientific evidence and stress that the real issue today is how much of that evidence is actually 
applied in the front lines of patient care. This might be regarded as the big paradox in health 
care innovation: while the technological and professional competencies have been progressing 
at a fast pace, the functioning of the health care system as a whole appears not to have 
profited from this progress. Research from the last decade indicates that a complex of factors 
is responsible for the malfunctioning of the innovation funnel in health care. Qualitative 
research (Adler et al. 2003) into the implementation of clinical pathways shows the 
importance of the organizational learning capacity in determining the success of change 
efforts in hospitals. Other authors (Striem et al. 2003) point to the impact of the professional 
autonomy on management induced change programs. Medical professionals, for example, 
appear to regard Total Quality Management (TQM), as a break with the firmly entrenched 
tradition of professional self-control of quality, and as a result do not commit themselves to 
the change efforts (Adolfini 2003). 
 
All these observations underline the importance of knowledge about the process and 
context of health care innovation. Research in this area is still in its infancy (Tabak and Jain 
2000). This applies to the service sector as a whole (Miles, 2004). Service organizations have 
been neglected by innovation researchers because they were assumed to be “innovative 
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laggards” (Miles 2004, p.63). However, the undeniable growth of the service sector as a part 
of our economy, has led an increasing number of researchers to turn their attention to service 
innovation. The pioneering work of Coombs (2004), Miles (2004), Tether and Metcalfe 
(2003) indicates that the relevance of models, typologies and concepts from the 
manufacturing industry for the study of service innovation is rather limited. Service 
innovation takes a wide variety of forms, but shows to have a number of characteristics, 
which need to be analyzed. The crucial role of the customer in the innovation process is one 
of these characteristics. It is recognized now that innovations take place within the context of 
intensive interactions between the service provider and the service user, as well between the 
service provider and equipment suppliers (Tether and Metcalfe 2003). These complex 
interactions constitute multiple “systems of innovation”. Tether and Metcalfe (2003, p.2) 
argue that these systems often develop around identifiable sequences of problems, which are 
themselves framed by a number of contingencies (including the regulatory, cultural and 
technological). That means that the “problem” or the “opportunity” can be considered as the 
heart of the system of innovation. Both writers point out that as the problem (or opportunity) 
changes, or is redefined, the system can change and for the same reason the agents and the 
relationships between these agents can change too. The implication is that there is not a 
“single system” of innovation in services, but instead innovation takes place in a multitude of 
different systems or patterns, which involve agents from different sectors. 
 
This characterization seems applicable to health care as it points up the complex 
nature of the innovation process. At the same time, there is an urgent need for knowledge 
about the context and process of innovation in health care that can help to make innovation 
programs more effective and less time consuming. To date one can see the emergence of a 
new line of research dedicated to innovation, its diffusion and implementation in health care. 
The number of studies remains rather limited (for example: Denis et al. 2002, Lemieux-
Charles et al. 2002, Metcalfe and James 2001, Robinson et al. 2003) and the field is still 
fragmented. It is suggested in this paper that a framework for understanding the innovation 
within the health care context might help to accumulate knowledge in this domain.  
 
The present paper aims to contribute to the development of such a framework. The 
paper is meant to map the routes innovations have to travel through the health care system 
before they finally become implemented. The emphasis is on managerial, organizational and 
institutional barriers for diffusion and implementation. The paper follows a systems 
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perspective (Carlsson et al. 2002). A map of the health care systems is used to allocate 
patterns of innovations. Two basic system dimensions  are distinguished. The primary process 
of health care is referred to as the horizontal dimension. The cooperation between functions 
and disciplines that contribute to the primary process is regarded as a crucial factor for 
innovation. The second, and vertical dimension concerns the different system levels at which 
policy-makers, managers and professionals are working. The paper tries to identify the walls  
in the primary process that have to be leveled, and the ceilings between different system 
levels that have to be  broken through in order to free the way for effective innovation. 
The description of the innovations patterns is done from a patient-centered 
perspective. The focus is on the downstream part of the innovation trajectory, the diffusion 
and implementation of innovations in the primary process (“front-end”) of health care. It is 
the area, where the final impacts on patients and care providers become visible. The paper 
first describes the patient-centered perspective and the three basic forms of health care 
innovation., and then elaborates on the two basic dimensions of the innovation system. The 
implications for further research, and innovation management conclude this paper.  
  
 
2. Methods 
 
This paper was born out of the participation in two EU-funded research projects: 
INNOFLEX (www.innoflex.org.uk) and Publin (www.step.no/publin). The projects 
developed a research line concerning innovations in health care services and were, and are 
carried out by networks of more than eight European research centers. The primary aim of the 
INNOFLEX project was the exchange of knowledge and experience among the participating 
hospitals, and the transfer of that learning to a wider audience. This project showed how 
difficult it is to compare and integrate case material from the participating research groups. 
Site visits and workshops in which researchers and hospital representatives made it possible to 
share each-others experiences and to make interpretations of the observations. In this sense, 
the project might be regarded (Engelstad and Gustavsen 1993) as a “network project”.  The 
second project is carried out in a similar setting, which might be characteristic for many EU-
sponsored projects. The experiences that were gathered in the first project, were used by the 
researchers as input for the second project. Publin was more explicitly aimed at theory 
development. At the start of the project it had been recognized, that the researchers needed 
more common ground to exchange their findings and to embed the theory development 
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process. On the one hand this setting is far more complex than in multiple case studies where 
theory building is carried out by one researcher or one team of researchers (see:  Eisenhardt 
1989). However, the advantages have also become evident in the course of this project. The 
setting offers the possibility to build theory in an iterative way: going forth and back between 
the observations, the interpretations by the network members, and the framework in progress. 
In this respect the effort might be regarded (Strauss and Corbin 1990) as the theory building, 
grounded in observations made in the course of the project. In this paper we make use of the 
explorative efforts in the Publin project. Discussions took place during 4 workshops, and in 
depth interviews involving 34 health care managers, clinicians and policy makers. The 
authors gratefully made use of the project’s progress documents, and many inspiring 
discussions in the Publin network. The feed back of the framework in progress might be 
regarded as the most valuable input for this paper.  
  
 
3. Patient-centered care 
 
 “Patient-centered care” is more than a socially desirable concept. The concept 
represents a fundamentally different perspective on the operations of health care services. A 
perspective which runs parallel to the commercial equivalent of customer-centered (rather 
than provider-centered) service. Patient-centered care means that (Sherer 1993, p. 14)  
(1) as many services as possible are put as close as possible to patients,  
(2) work is redefined by desegregating job tasks and providing staff with the 
necessary support, skills, education, and training,  
(3) meeting the needs of patients, not of departments and disciplines.  
This perspective implies the integration and decentralization of functions close to the patient, 
interdisciplinary teamwork and shared decision-making. This approach is also referred to as 
care for the whole patient, because it does not restrict the care to one or a few aspects of the 
patient, but deals with the whole person (for example: www.dukehealth.org ). In the concrete 
language of the practice of health care this means that a team of professionals pays attention 
to the whole situation of the patient, not only in terms of his or her medical condition, but also 
with regard to his or her functioning in wider systems: the family, work and school.  
Integrated (to avoid using the word “holistic”) care starts with prevention and extramural care 
and runs across the walls of the intramural care, back to the living and working environment 
of the patient and his or her family. Many health care institutions, all over the world have 
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adopted this perspective to communicate their intentions. See for example: www.gooi-
noord.nl, www.buffalohospital.org  and www.planetree.org (see box 1) 
 
 
 
Patient centered care 
At Buffalo Hospital, every employee knows that you are our first priority. Our services are designed to 
meet all of your needs in an atmosphere that promotes healing and comfort. We want to make what 
can be a stressful situation as comfortable as possible for you and your family. We believe it is 
important to involve and educate you and your family about your medical condition and treatment 
options.  
Nursing care second to none 
Our nursing staff’s responsiveness and level of personalized, skilled care is second to none. Survey 
results show that the strong, personal connection our nurses make with their patients stands out as 
one of the most satisfying parts of their hospital experience. 
By making your health care experience more positive, we believe we can help you heal better. 
 
 
Box 1: Patient-centered care (www.buffalohospital.org) 
 
The perspective of patient-centered care provides inspiration for the design and 
development of health care services. This view implies the shift of focus from the 
development of individual crafts towards process development and organizational learning 
(McLaughlin and Kaluzny 2000). Clinical pathways are regarded as instruments for this 
learning process. Clinical pathways can be regarded as interdisciplinary road maps or guides 
for action given a particular diagnosis, based on consensus among care providers and are in 
line with the state-of-art (Adler et al. 2003, p.33). They address all care providers. Clinical 
pathways are meant to promote clinical and organizational practices grounded in scientific 
evidence (Denis et al. 2002). “Evidence-based decision making” aims to close the gap 
between what is known and what is used in practice (Denis et al. 2002, p.60, cf. Sackett 
1997). Essential in these approaches is the reference to medical practices and medical 
knowledge. The patient-centered perspective is also used in innovations with labels from 
managerial language: total quality management (Adinolfi 2003), re-engineering (Ho and 
Kidwell 1999), continuous improvement (Adler et al. 2003). One might hypothesize that these 
differences in wording reflect the “ownership” of the various approaches rather than the basic 
principles.  
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Modern information and communication technology (ICT) is often seen as a key to the 
improvement of the health care delivery system in general (Wholey et al. 2000). ICT can both 
be regarded as a driver of re-engineering and as a support, a tool, of the clinical primary 
process. It is argued (Simpson 2003) that ICT can be a powerful tool for realizing the 
development of patient centered care. The use of hand held technology, for example, can be 
used to bringing nurses back to the bedside (Simpson 2003). The cost cutting strategies of the 
1980s and 1990s, invariably targeted nurse staffing levels and put the bedside care process 
under increased pressure. A new generation of clinical information systems (CIS) can reduce 
the time spent on non-care tasks and give “nurses the one thing they really need more of- 
time” (Simpson 2003, p. 14). In the same vein the internet is opening new ways to bridge 
geographical distances and to bring care closer to the patient (Robinson and Savage 2003).  
 
4. The map as a representation of the system 
 
The maps to be drawn in this paper can be regarded as spatial representations of the 
innovation system and are meant to gain insight in the emergence of these patterns. The focus 
of this study is on the diffusion and implementation phase of health care innovation. The 
observations above imply that the maps should be drawn from the perspective of the patient. 
Or in systems language: the build up of the picture of the system is bottom up rather than top 
down. The primary process of health care is the starting point for the exploration of the 
innovation system. Secondly, the maps should offer the possibility to visualize the multiple 
levels of decision-making and organizational learning (cf. Tucker and Edmondson 2003). 
Observations like the ones above indicate that interactions between different levels are 
frequently problematic in health care innovation. Finally, the maps should show the feed back 
mechanisms within the health care innovation system, the basic question being: how is the 
impact of innovation monitored at different system levels?  
In line with sociotechnical systems theory (De Sitter et al. 1997) the map of the health 
care innovation system is built up along two basic dimensions: (1) the structure of the primary 
process (or: production structure), in which inputs are transformed in systems outputs, and (2) 
the structure of the planning and control functions (or: the control structure). The primary 
process is represented in the mapping as the horizontal axis. The horizontal axis serves to 
identify the needs for integration of and cooperation between the different connections of the 
health value chain.  The vertical axis represents the control structure and positions the key 
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echelons of management and policy-making: from the operational, or peer level, management 
level to the systems (or policy) level.  
 
The systems approach is broadly accepted as a tool for the analysis of economic and 
technological change (Carlsson et al. 2002). This paper focuses on the analysis of the 
innovation system in health care. The function of the innovation system is according to 
Carlsson et al. (2002, p.235): “… to generate, diffuse, and utilize technologies (physical as 
well as technical know-how) that have economic value”. A system consists of components, 
relationships and attributes. 
We start our mapping exercise with a tour of the constituting elements of the system. 
First of all there are the components. Carlsson et al. (2002) describe components as the 
operating parts of a system (p.234). These can be actors (e.g. patients, health care 
professionals, managers, politicians), organisations (e.g. hospitals, nursing homes, community 
care centres, insurance companies, professional bodies, patient organisations, manufacturers, 
universities), institutions (e.g. regulatory laws, inspection, watchdogs) or artifacts (e.g. drugs, 
diagnostics, equipment, implants). We will not try to make a complete list of possible 
components. As Carlsson et al. (2002) point out, the system boundaries, the actors involved, 
the networks and institutions may vary depending on how we choose the level of analysis. 
Tether and Metcalfe (2001) make a similar point when they say that the problem or 
opportunity at the heart of the ‘system of innovation’ becomes the focusing device around 
which the system is developed. Thus, as the problem or opportunity changes, or is redefined, 
so the system can change, changing the agents involved and the relations between these 
agents. In the present paper we are not concerned with one particular innovation or set of 
innovations, but rather with the performance of the health care system as a whole and the 
main features of that system. 
The second element of a system consists of the relationships between the components. 
Again, much will depend on the specific innovation under study. Tether and Metcalfe (2001) 
describe how systems that generate innovation can be regarded as sets of micro systemic 
elements that are created around sequences of problems or opportunities and involve shifting 
patterns of interaction as new problems or opportunities emerge and draw upon different 
kinds of specialised knowledge. 
Finally, the third element of a system consists of the attributes; the properties of the 
components and the relationships between them Carlsson et al. (2002). These attributes 
characterise the system, they are the features which are crucial for understanding the system 
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and are related to the function or purpose served by the system. The main features of an 
innovation system are the capabilities of the actors to generate, diffuse, and utilize 
technologies that have economic value. Our mapping exercise will result in the description of 
a number of attributes of the healthcare innovation system. 
In the course of this paper we will draw on studies that provide in depth analysis of 
innovation at the micro level, so that we can see the components and relationships in action. 
This allows us a peek into the system and gives the necessary empirical grounding for our 
analysis. We will however concentrate on the issues addressing the effectiveness of the 
system as a whole to perform its function: innovation of healthcare delivery. 
 
 
 
5. The horizontal axis: health care as a process 
 
Health care is often portrayed (Minzberg 1979) as a professional bureaucracy. This 
means that the functions (disciplines) are the basic building blocks of the system. A formal 
system of rules and regulations serves to integrate these specialized units. Within this context 
the professionals have a high degree of autonomy. Traditionally the professional autonomy of 
doctors has been regarded as a cornerstone of health care. The functional organization can be 
regarded as a fruitful environment for the development and implementation of new methods 
and health technologies that have their roots in the medical specialisms. These innovations 
often have a scientific or technological origin, for example use of lithotripters, laser-guns and 
psycho-pharmaceuticals. We propose to call them functional or clinical innovations, because 
they have their roots and main impacts in the disciplines, or professions of health care. 
Research and training centers, equipment and drugs suppliers, and the communities of 
practice of the professionals form the system of innovation in which new treatments can be 
developed.  Modern cataract surgery, by which the natural nontransparent lens is removed and 
replaced by a plastic lens, which is placed inside the eye, is an example of a complex 
functional innovation. This innovation (box 2) is based on decades of technical and clinical 
development and has become an icon of modern medicine. 
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“You have a cataract in your right eye” says the ophthalmologist. “A small, hardly burdening operation 
will solve the problem. In this hospital we do more than 5000 of these operations a year. The surgery 
itself takes less than half an hour. You can go home an hour later”. The patient, coming back from the 
surgery, can hardly imagine what development work had to be carried out, in order to design this 
seemingly routine operation, which today can be performed in most local medical centers. It took more 
than three decades to perfect the original idea of the British eye doctor Harold Bingham. Until the 
eighties the technique was viewed with considerable hostility by the ophthalmic profession. Today it 
the most frequent outpatient surgery among people above the age of 65. The development of this 
functional innovation has been a long path of trial and error. That path has been the search for new 
operating techniques, new materials, and new equipment. Crucial in this development has been the 
technique, developed by Charles Kelman in the United States, used to fragment the cataract by 
ultrasound and remove the debris by a pump mechanism.  The foldable lens, surgical microscopes 
and new anaesthetic methods have been other complementary innovations required to reach the 
present level of ophthalmic treatment. Metcalfe and James (2000), made an excellent case study into 
the development of the IOL-surgery, and their report has been used in writing this box. The case study 
shows that during these three decades of ophthalmic research and development, a very complex 
system of innovation co-evolved with the innovation itself. The ophthalmic community of practice, 
leading medical centers, material and equipment manufacturers formed a system of distributed 
capabilities and complementary assets.  
 
The innovation process does not stop there. The availability of crucial new knowledge, new evidence-
based medicine does not in itself (Van de Ven and Schoemaker 2002) change the practices and 
processes in the health care service. That requires complex changes in the health care delivery 
system. The final social impact of the IOL-innovation is in fact only realized on the moment the delivery 
system is ready to perform the treatment as a routine and the health insurance companies pay for the 
treatment. One might speak in this respect of the “diffusion phase” of innovation. However, from the 
perspective of the health care services it might still be better to talk about “real innovation”. The eye 
clinic in Rotterdam is a good example. The clinic was almost closed, more than ten years ago. The 
management and clinical staff made the decision for a radical streamlining of the treatment process in 
order to turn away from the closure. The clinic is now regarded as a highly successful example of 
health care innovation. In order to reach that level of performance a coalition of management and 
professionals had to rebuild the whole organization and all of its care processes. That means the 
introduction of innovations in almost every part of the service process, including new clinical pathways, 
new technologies, parallel production lines for the main types of treatment, logistics, surgery and care 
teams, training programs, patient education and reconstruction of the building. 
 
 
Box 2: Functional innovations and process innovations: the intra-ocular lens (IOL) 
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Our first explorations in the literature showed a wide variety of actors involved in 
health care innovation, and of drivers and barriers of change. Health care appeared to be the 
stage where many professionals, managers and policy-makers (and patient-organizations) are 
involved in numerous efforts to develop and implement new service patterns and systems. 
Schrijvers et al. (2002) show that care can be made more effective, safer, faster, patient-
friendly, efficient and professionally satisfying. The researchers describe 21 innovation 
projects in the Netherlands that make everybody a winner: the patient, the doctor, nurse and 
tax-payer. However, the diffusion and implementation of these good and often proven ideas in 
health care as a whole appears to be a serious problem. Many writers have pointed to the gap 
between what is known and what is used in practice (Denis et al. 2002, Lemieux et al. 2002, 
Sackett et al. 1997, Schrijvers et al. 2002). 
 
Research into the diffusion process of functional (“technological” or “medical”) 
innovations is still in its infancy. We still lack the knowledge to understand (Denis et al. 2002, 
p.61) why some less solidly supported health care innovations are widely adopted, while 
others with apparently stronger scientific support remain underused. The recent study of 
Denis et al. (2002), comparing diffusion of four innovations (low molecular weight heparin 
for deep vein thrombosis, laparoscopic cholecystectomy, multiple use of dialysis filters and 
assertive community treatment) indicates that the adoption is more likely to take place in 
contexts where the benefits and risks connected with the new practice fit with the maps of the 
interests, values, and power distribution of the actors and their organizations. Overadoption of 
laparoscopic cholecystectomy, can according to the authors, be explained by the presence of  
a strong pro-adoption coalition, consisting of patients, hospitals and insurance companies. 
Research into the management of technological innovation in health care appears to be of 
increasing importance because of its role as major driver of health cost (Docteur and Oxley 
2003, Fuchs and Garber 2003). Too much money is invested in the development of high-end, 
complex technologies, and too little is invested in (“disruptive”) technologies that simplify 
complex problems (Christensen 2000, Fuchs and Garber 2003). Driving forces of the 
decision-making process remain unclear in this context. 
 
Process innovations are of a different nature. They concern the innovations that are 
implemented in the whole sequence of treatments and care activities patients undergo. In 
 14
economic terms one might speak of the “health care value chain”. In this view health care is 
regarded as a system of interconnected subsystems for prevention, intake, treatment, care and 
aftercare. These subsystems (see figure 1) are mostly part of institutions of organizations (like 
hospitals, nursing homes, rehabilitation centers and home care) or are operated by individual 
medical professionals (family doctors, physiotherapists and visiting nurses), and not to forget: 
by the family and volunteer aid. The thick arrow in figure 1 represents the broad pathway for 
patients with a certain type of disorder, and the thin arrow the pathway traveled by an 
individual patient. 
 
WALLS
innovation environment
system innovation
functional 
innovation
primary careÆhospitalÆrevalidationÆhomecare
Between
primary care 
and hospital
care
Between
disciplines
Between
services
Between
in- and 
outpatient 
care
Firms, knowledge 
centers, advocacy 
organizations process innovationDiscipline,function
 
 
Figure 1: Health care as a process. 
 
Functional innovation in health care can be compared to the design of production tools 
in industry. Innovation in the health care process is similar to the design of a production 
process as a whole. A fundamental characteristic of process innovation is that most of the 
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improvements of productivity and quality are realized by integration, cooperation and 
adjustments between the subsequent subsystems. Process innovation is by definition cross-
functional. To date, the development of clinical pathways can be considered as the most 
predominant process innovation in health care. One might regard clinical pathways not only 
as a formal system that safeguards the use of state-of-art medical practice, but also (cf. Adler 
et al. 2003) as a means to organize care process. This implies that professionals have to 
become aware, that evidence-based medicine requires more than formal protocols: it requires 
new organizational forms in which new ways of treatment can be embedded. As medical 
knowledge and know how advances, the pathways have to be maintained continuously. The 
aim of clinical pathways is in the first place the improvement of the quality of the care process 
as a whole (Field and Lohr 1992). This aim is close to process innovations and not far away 
from change programs with more “business-like” labels, like Total Quality Management 
(TQM), Re-engineering, and Continuous (Clinical) Improvement. The basic idea is that the 
quality of the actions is to be monitored at each step of the process in order to safeguard the 
final quality the “customer” may expect. In this view, quality pays out, because effective 
treatment is the best way to control costs.  
McLaughlin and Kaluzy (2000) argue that process innovation in health care can be 
considered as part of a more fundamental development: the unfolding industrialization of 
health care. Industrialization represents a move away from the craft model where health care 
is “…being delivered by professionals who practiced an individual craft or art, learned by 
apprenticeships, work independently in a decentralized system, tailored to each individual 
situation using processes that were not recorded nor explicitly engineered, and were held 
personally accountable for performance and financial outcomes” (McLaughlin and Kaluzy 
2000, p. 74). The writers forecast a development in which health care will move through 
process improvement and enhancement toward mass customization. The “focused factories” 
or “specialty hospitals” might be considered (Casalino et al. 2003) as the icon of this 
industrialization and rationalization process (see: box  2 and 3). In analogy with the modern 
production lines of car producer Toyota, health care entrepreneurs try to outcompete and 
outperform traditional facilities by dedicating staff, equipment, and management attention to 
one specific types of disease.  
These developments are not only a source of revenue, but also of controversy (Voelker 
2003). Part of the professionals fears that the standardization of medical processes, as 
advocated in the development of clinical pathways infringe upon their professional autonomy 
and flexibility (Timmermans and Berg 2003). The focus of health care services on “standard 
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cases” is criticized because it could lead to unfair cost advantages by “cherry-picking” 
(Casolina et al. 2003). 
 
 
 
The Deacon hospital in Voorburg (The Netherlands) is on its way to become a focused factory. The 
concept originated in the manufacturing industry, and is increasingly used for hospitals and wards that 
are focused on and equipped for the delivery of one type of care for a clearly defined category of 
patients. Well-known examples are the Shouldice clinic for groin hernia in Toronto and the cataract 
production line of the eye hospital in Rotterdam. However, nowhere in the world are the principles of 
focused factory are being used at the scale of a complete hospital. “Here in Voorburg, we want to be a 
center of excellence for varicose veins, gallbladders and groin hernia,” says surgeon Koning. “To be 
effective you have to build a large body of experience and preferably work in steady teams. That’s the 
way to become better and faster. By using the same operating room for the same type of surgery, no 
special arrangements are needed. When you do ten of the same operations at the same day, with the 
same team, you are improving all the time. Crucial is the selection of patients. Patients with 
complications are not fit for treatment in a focused factory. They will be treated in our sister hospital in 
Delft” (After: De Volkskrant, February 7th, 2004) 
 
 
Box 3: The focused hospital 
  
 
Modern information and communication technology (ICT) is supposed to play a key 
role in this rationalization process (Wholey et al. 2003). ICT is expected to free health care 
providers from the tyranny of paperwork. Given this promise (and the high price that has to be 
paid for that promise), it is remarkable that little is known about the progress that health care 
services have made in fulfilling that promise (Wholey et al. 2003). The available data show 
that most health care services have developed considerable administrative system capacity, 
and that relatively little work has been completed developing clinical systems and integrating 
clinical with administrative systems. Today, the basic discussion is about the big step health 
care institutions have to make: from island automation and systems integration towards the 
implementation of a basic information infrastructure. Such an infrastructure is a basic 
requirement for the cross-functional collaboration. It does not require much fantasy to see that 
ICT is crucial for the implementation of almost every type of process innovation. At the same 
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time one has to conclude that the same divide between management-driven and clinical-
driven change is evident here. 
 
Cross-functional cooperation is the most important prerequisite for process innovation. 
In recent literature the lack of that cooperation is mentioned as one of the most serious 
barriers against process innovation. Adler et al. (2003, p.22) followed the introduction of 
clinical pathways in seven pediatric hospitals for a year and speak about the striking lack of 
horizontal communication systems. The earlier comparative case comparison of Savitz et al. 
(2000) in four American integrated delivery systems pointed in the same direction. Adinolfi 
(2003) studied the implementation of Total Quality Management in seven Irish and seven 
Italian hospitals and made a similar observation in both countries. She saw little evidence of 
team-working across entire specialties or groups of specialties in TQM projects. Illustrative in 
this respect is the finding in a study on work attitudes of nursing department employees, that 
job tension and job withdrawal attitudes are negatively associated with inter-department 
cooperation rather than with intra team cooperation (Carson et al. 2001).  
 
 Professional autonomy is regarded by most writers as the underlying source of 
resistance. It appears that walls and barriers between functions and disciplines have to be 
pulled down. This applies both to the functions within the walls of a health care institution 
(intramural cooperation) and across the walls of intra and extra-mural services. This does not 
exclusively concern the interaction between professionals. Process innovation also requires a 
basic change in managerial perspective. Management is challenged to change its focus from 
optimizing the performance of separate functional units toward optimizing the final outcomes 
of the health care process as a whole. Box 4 gives a good and a bad example.  
 
 
 
A lady in her mid 80s is admitted to a general hospital. She has a problem with her esophageal (or: 
gullet). The treatment she has to undergo, the stretching of the esophageal opening, is no pleasure.  
After the treatment she has to learn to eat again, or better, swallow solid food. That can be a rather 
painful experience. Nurses used to sit at the bedside of such patients to “talk the food inside”. The risk 
is, that when they do not try, patients will keep eating soft food like yoghurt and custard. That will 
substantially increase the chance of a relapse. The nurses are under such time pressure that they are 
unable to give this patient the right attention. Nobody is held accountable for future costs. 
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A stroke center of a medium sized regional hospital maintains close relation with the local 
rehabilitation center, the nursing home, and home care organization. Twice a week, they discuss the 
cases “in the pipeline”. That means that rehabilitation can be planned from the moment of hospital 
admission and that situations can be avoided in which patients have to stay in the hospital, because 
there is no place in the rehabilitation center or in the nursing home and no capacity for home care. 
 
 
Box 4: Thinking ahead. 
 
The use of the verb “challenge” may sound rather euphemistic for many change agents in 
health care. Savitz et al.(2000, p.372) point to the “...existence of financial disincentives to 
system improvement, that result from traditional accounting practices”. According to them, 
innovators are often frustrated by the lack of recognition of system savings. They propose to 
assess the system savings for clinical improvement programs and to use activity-based 
accounting (Kaplan and Cooper 1998) to attribute them back to the innovating team.  
 
The problems related to the cooperation in the development chain are extensively described in 
the literature on innovation in industry (for example:  Cooper 1994, Den Hertog and Huizenga 
2000, Rosenau et al. 1996). The proposed solutions all point in the same direction: multi-
functional development teams, stage-gate models for product development, customer 
involvement, overlapping development phases, etc. Although it seems rather appropriate to 
look for parallels with industry, one warning might be given. The process of health care is not 
simply a “delivery system” (cf. Green, Howells and Miles, 2001). Changes in the delivery 
process de facto constitute changes in the content of the care given. For example, a special 
outpatient service for suspected breastcancer, the so-called mamma clinics in the Netherlands, 
not only provides multidisciplinary care, but also faster access and shorter waiting times for 
test results. Therefore, patient anxiety is reduced and treatment can be started sooner after the 
initial referral by the GP. Cooperation and communication between health care professionals 
often results in “different (and more effective) kinds of treatment”. The one-to-one transplants 
of industrial practices are often (Striem, Ovretveit, and Bommels 2003) not such a success. 
Practical experience shows that new ways of working have to be rooted in the professional 
groups in order to raise real engagement. To implement them in the context of health care is 
not expected to be easy, because different from industry, health care providers are only just 
beginning to think in terms of processes.  The call for professional autonomy is an easy way 
to shut all doors and fences of  functional units for blocking concerted action. 
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6. The vertical axis: echelons of power 
 
The process described above concerns the organization of the health service at the 
level of the service organization. It is the level of operations. A lot of problems are solved at 
this level of the acting professionals: the operation (or: peer) level (figure 2). Continuously 
numerous decisions have to be made during the care process. De facto, the decisions at the 
operational level determine to a large extent the actual behavior in a ward or in a service. 
Many initiatives for clinical improvement (Savitz et al. 2000) can be regarded in this 
perspective as “grassroots innovations”, implemented by clinicians or clinical teams as 
remedies for identified problems. The clinical (or: functional) units of health service 
organizations are traditionally managed by the highest ranking professional. Although new 
managerial positions next to, or above the position of the chief professional are introduced in 
many health care organizations, the latter often still dominates the decision-making within the 
functional units. Management at level 2 plays a crucial role in the introduction of functional 
innovations: the introduction of new technologies and new medical techniques. This role is 
twofold. The professionals are both adopters (“recipients”) of new technologies and new 
techniques and initiators for process innovations and functional innovations.  At the same 
time unit management has the responsibility to implement the managerial policies from level 
3: realizing the budget, implementing new management systems and personnel policies. 
 
The unit head reports to the management of the institution, which we shall address as 
service management or level 3 management. Management has been professionalized to a large 
extent in the last ten years: at  service management level professionals acting as managers are 
increasingly exchanged for professional managers. The care process is moved to the 
background. The economics of the institutions, social policy, the regional or national 
cooperation with other institutions are in the foreground.  
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Figure 2: Echelons in health care 
 
The deliberations at this level are often far removed from the content of the care process. The 
agendas of the board members are filled with meetings with external policy makers of 
regional or national government, regulators, the insurance companies, and of other 
institutions. In this way the directors of the health care services sit from time to time at the 
meeting tables of the next level of decision-making. They are under constant pressure from 
national and regional policy makers, health care purchasers and insurance companies to 
reduce costs and support cooperation and share care tasks with other health institutions. The 
interface between service management and unit management is regarded as a crucial factor in 
health care innovation. Recent research (Striem et al. 2003, p.256, Adolfini 2003) indicates 
that one even might speak of the “detachment of management from professional practice”. 
This divide can be regarded from two perspectives. Striem et al. (2003) suggest that this 
detachment is greater than in many other knowledge intensive industries. This causes tension 
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as physicians are perceived by management to be unwilling to give up part of the control of 
their professional territory. Consequently, process innovations, which are meant to cross 
functional borders, are often perceived by the medical staff as “managerial issues”. The 
agenda is seen as set by management rather than by the professionals. At the same time it is 
being recognized in the same literature that process innovations like TQM, clinical 
improvement and re-engineering only make sense, when the physicians take an active role in 
the change program (see box 5). 
 
 
 
The medical superintendent of a psychiatric hospital: “In the beginning of our change process we 
called in consultants of this well known consultancy firm. They hardly understood anything of our 
primary process: the care and treatment of patients. A real understanding of that process is key for 
any change effort. Only once you have that understanding, and know the content of your new design, 
all those management models and concepts prove their value. So, (…) here you’ve got our recent 
implementation plan. You can see, we are going for business process re-engineering”.  
 
  
Box 5: Making sense 
 
 
Professionals may hold another perspective. Many innovations (Savitz et al. 2000) are 
born at the operational level (level 1), and are inspired by shared values of the professionals. 
Small groups of professional develop solutions for the problems they encounter in the service 
process. These new solutions mostly require the consent of functional management, and many 
things can be arranged locally at the operational level, when the professionals are willing to 
cooperate and no substantial investments are called for. When the initiators aim to transfer 
their practices, ask for cooperation of other functions and ask for extra budget they often meet 
the ceiling of the higher echelons. The cited Dutch study into health care innovations 
(Schrijvers et al. 2003) shows how frustrated the initiators of these bottom-up innovations get 
by the slow reaction from higher echelons. 
 
 The causes of this basic problem have been searched in many directions. The study of 
Schrijvers et al. (2002) points to multiple factors that slow down the process of change, 
including: disinterest among managers, rigid financing systems, time pressure at the service 
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level. Savitz et al. (2000, p.372) speak in this respect about “the existence of financial 
disincentives to system improvement”. They hypothesize that institutions would be far more 
eager to adopt new practices, if there were financial advantages to be gained. In exchange for 
more funds insurance companies would demand more information about the effectiveness or 
outcomes of the new schemes. The authors make a plea for more openness about medical 
performance of health care institutions. Others (Striem et al. 2003) point at the detachment of 
management from professional practice and the strong resistance of care providers to give up 
any bit of professional autonomy. This tendency to defend and close off professional territory 
and to escape from shared responsibility might be regarded as a major barrier for innovation. 
Conflicts of interest between health care institutions, professional groups, insurance 
companies, patient-associations and (local) government play an important role too. Or 
formulated differently: “(…) the benefits and risks of the innovation are distributed unevenly 
among the people involved” (Denis et al. 2002, p.66). The authors show how innovation 
patterns in health care are embedded in collective and organizational contexts. 
  
  In the worst case the effect can be a real vacuum between level 2 and level 3. That is 
the situation when professional and managers are living in separate worlds, without pathways 
to connect those worlds (see box 6). 
 
 
The management team of a regional general hospital meets once a month to develop new policies. 
The process is cast in a seemingly effective form: task groups are set up, their homework is carefully 
defined and planned. The results are discussed in the medical council, the workers council, and the 
new policy papers are distributed among the medical and managerial staff. When a policy is defined, it 
disappears from the agenda of the management team. Nobody is doing a follow up. Moreover, hardly 
anybody is actively involved with the implementation of the new policies. There appears to be a silent 
contract: the professionals are not objecting to the new policies as long as they are not forced to 
implement them. Management won’t check their progress in their professional territory, as long as they 
are not obstructing the policy-making process.  
 
 
Box 6: Living in different worlds. 
 
A comparative study (Adolfini 2003) in 14 Irish and Italian hospitals shows, that hospital 
management often constructs formal compliance mechanisms in reaction to institutional 
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pressures concerning the quality of health services. They adopt new vocabularies, create new 
departments and procedures, while the diffusion of the process innovations remains limited to 
a few single units. By keeping up appearances they charm health purchasers and regulators, 
without disturbing the local status quo.  
 
Service management (level 3) operates in a similar field of tension. On one hand there 
is a constant pressure from health purchasers and regulators to reduce cost drastically. Service 
management has to pass on the bad news to functional management, while room for further 
traditional cost reductions seems to become smaller and smaller (Volkskrant March 18th, 
2004). At the same time purchasers and regulators tend to believe strongly in the relevance of 
managerial ideas: health care services should be run as private firms (Adinolfi 2003). One 
lesson that has been learned is that physicians should be strongly involved in process 
innovations (Striem et al. 2003, Lemieux-Charles et al. 2002), even (Striem et al. 2003, p.257) 
should “take the lead”. However, in practice this involvement appears to be absent in many 
cases (Adinolfi 2003, Striem et al. 2003). The unwillingness to give up part of their 
professional autonomy has been mentioned already as an underlying cause. In this context the 
cost reduction and downsizing become easy arguments (Adinolfi 2003) for non involvement: 
“We don’t have the time left”.  Service management is also stimulated by policy-makers to 
make deals with neighbouring health services to pool specialized staff and new expensive 
technologies. In turn, such measures have to be “sold” to the professionals. The measures 
might be in flat contradiction with the propositions for innovation and improvement brought 
forward by the professionals.  
 
Many stakeholders operate on level 4: (regional) government, professional 
associations, insurance companies, health care purchasers an regulators, patient ‘s 
associations, health advocacy and research funding organizations, unions, politicians and 
other kinds of institutions representing other organizations (university hospitals, for example). 
The difference between countries with strong private health care markets, like the United 
States of America and countries with public health care systems is relevant in this respect. 
The pressure to reduce costs is high in both contexts. Both use regulators try to control costs 
(Berenson 1991, Reinhardt 1999). Public regulators can use budgeting and price-setting tools 
for this purpose. In the employer-provided health insurance system in the US regulation is 
carried out by private health plans. These health plans have the contractual right to regulate 
the treatments of the insured (Reinhardt 1999). Basically, they control costs by reduction of 
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freedom of choice between health care providers. This arrangement has been coined 
“managed care”. Health plans have adopted a variety of techniques to control cost and making 
sharp bargains in the purchase of health care services. Many of these techniques have been 
used under the label of “managed care” within public systems in Europe and other parts of the 
world (Azevedo 1996).  
 
Service-level innovation has been under-rated by policy-makers as an effective 
strategy for health care reform (Docter and Oxley 2003). The innovation of health care 
systems takes place at higher levels. The term innovation in the perspective of policy makers 
mostly refers to subjects like: universal insurance coverage, financing health care, 
privatization, adequate and equitable access, allocation of resources and safety inspection. 
Many writers point to the interrelations between innovations at micro and macro level (Docter 
and Oxley 2003, Schrijvers et al. 2002). These issues will be elaborated below.  
 
System innovation deals with the institutional and infra-structural measures of the 
health care industry as a whole. Innovations vary from relatively simple formal measures like 
the compulsory patient identification before hospital admission, to complex and time 
demanding redesign of a national insurance system. Legislation and budgeting are main 
instruments for change. Three broad categories might be useful to describe the innovation 
landscape at this level. The first one can be labeled as “health care systems reform” (Docteur 
and Oxley 2003), or “health policy innovation” (Walshe 2001). This reform is meant to deal 
with the deficiencies of the insurance market. The reform is mainly focused on the 
introduction of more and more effective (microeconomic) incentives for controlling the 
performance of the health care system. The introduction of these incentives through the 
creation of a more competitive environment has proved (Docteur and Oxley 2003) to be 
difficult because there is a lack of knowledge about the intended and unintended effects. 
These unintended effects can both originate from a lack of knowledge of the primary process, 
or by unexpected game playing behavior by patients and care providers (box 7). 
 
 
 
The Dutch government intends to shift part of the responsibility for mental health care to the 
municipalities. The expectation is, that by decentralizing support functions to the municipalities health 
care will be more effective, solidary, affordable and accessible.  In the case of mental care one might 
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even hope that this new policy contributes to the emancipation of psychiatric patients. The 
municipalities can offer a wider range of services for this target group and might get more eye for their 
citizens who have to deal with the long-lasting effects of their illness. Sweden has introduced a similar 
policy in the past. To date, this “Swedish model” appears to be in crisis. Especially the problems 
around chronically psychiatric patients prove to be difficult and complex. Anyway, too difficult and 
complex for the average municipal welfare worker. The welfare services are not professionally 
equipped to tackle the problems of the patients effectively. Some municipalities started to employ 
social psychiatric nurses, but that can hardly have been the initial intention of the policy makers. In that 
case the patients might as well have remained in the mental health services. The effects of this policy 
for chronic psychiatric patients have become visible in Sweden: restructuring the care effectively leads 
to neglect of patients, resulting in deterioration of their physical health and their disappearance from 
the monitoring activities of the general and mental health services. A more fundamental consequence 
is, that the right of access to health care is exchanged for the dependency of municipal welfare policy. 
After: J.C. Hoeveraars (2004). Mr. Hoevenaars is chairmen of the board of mental health services in 
Groningen (The Netherlands). 
 
“Men are asking for a medicine for vaginal fungi, while they need a remedy for their skin 
problems.” Paul Gebbink, pharmacist in The Hague has seen them in his pharmacy. “The usual variety 
of Daktarin is not covered by the insurance companies anymore, the one for vaginal use still is. There 
are physicians who prescribe the vaginal cream instead for men. We don’t cooperate with those 
practices.” (Volkskrant, March 12th, 2004).  
 
 
Box 7: Unintended consequences 
 
Recently, Porter and Olmsted Teisberg (2004) underlined that health care does not 
function like a normal industry, where competition drives up value for the customer over time 
as quality improves and costs fall. In contrast, they argue (p. 66), health competition becomes 
a zero-sum: “The system participants divide value instead of increasing it.” According to 
Porter and Olmsted Teisberg, competition occurs at the wrong level: the level of the health 
plans, networks and hospital groups. It should occur in the prevention, diagnosis, and 
treatment of individual health conditions. “It is at this level that true value is created -or 
destroyed – disease by disease and patient by patient” (Porter and Olmsted Teisberg 2004 p. 
66).  
 
The second category of system innovation deals with general measures to improve the 
effectiveness of local health care systems. One might speak in this respect of “health care 
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management innovations”. These innovations are directed at a broad range of measures: 
improvement of information about health care, promotion of quality improvement, 
introduction of modern information and communication technologies, support for research, 
experimentation and diffusion of best practices.  
The last type of system innovation is focused on the improvement of regional health 
care system. Cooperation and integration of local health care services serve to improve the 
functioning of the health care value chain. These efforts are aimed at developing cross-
institutional patterns of action or “integrated clinical pathways”. One might think about the 
agreements (figure 1) between hospitals, rehabilitation centers and home care about the policy 
for the treatment of patients with specific health problems. 
 
Service management plays an important role on the systems level of innovation as 
well. A quick look in the agenda’s of board members will show that most of their time is 
filled with appointments with representatives from other institutions. No wonder there is so 
little time to develop dialogues inside the own organization. The cooperation with 
neighbouring health care services appears to be a time-consuming process.  
The system level is both the level of interacting bureaucracies, as the open political 
arena where almost each group of stakeholders plays its role. Again one hears policy makers 
complain about the resistance to change among professionals, service managers and local 
policy makers. At the same time the latter need little encouragement to give colourful 
accounts of the madness in the system.  
 
 
  
 
7. Better practice  
 
Our exploration of both literature and practice shows many walls and ceilings in the 
health care innovation system. The walls in this metaphor refer to the borders between 
functional domains in the innovation process and the ceilings to the demarcations between 
system levels. This explorative study indicates that walls and ceilings create serious barriers 
for the diffusion and implementation of innovation in health care services. Using a systems’ 
perspective appeared to be helpful for mapping these barriers, and (cf. Carlsson et al. 2002) 
for unravelling the process of innovation and diffusion within health care.  The use of systems 
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theory also helps to understand the mechanisms that hamper innovation performance in the 
industry. Two of these mechanisms are identified in this study. Both are dealing with the 
malfunctioning of the feedbacks in the system. The first mechanism is connected with the 
walls between the functions (disciplines or services) along the health care value chain. Most 
of the feedbacks are predominantly concerned with throughput and output measures within 
functional domains and do not regard the throughputs and outputs of the value chain (or “care 
process”) as a whole. The effect is sub-optimization. Box 4 exemplified the differences 
between piece meal and integrated (anticipatory) feed back systems.  
 
The second mechanism that limits the performance of the innovation system in health 
care concerns the vertical dimension of the system. Innovations can take place at different 
levels of the system. This study identified four relevant levels: the operational level, 
functional or unit level, the service management level and the system or policy level. The 
basic problem is that the impacts of the interventions are often only established at the level of 
the intervention. Consequently the agents of change remain uninformed about the effects on 
higher or lower system levels. Policy measures at the national level (box 7) may have 
unintended consequences at the operational level. On the other hand, innovations at the 
operational and functional level might often require complementary measures at the 
management and system level. Experiments with long term objectives might for example 
require extra funds or consent from health care inspection and regulators.  
 
These mechanisms should be recognized in efforts to improve the performance of the 
innovation system. Three approaches to tackle the situation can be discerned as a result of this 
study. The first deals with the translation of the idea of evidence-based medicine to the 
practice of organizational change: evidence based change. The second stresses the importance 
of innovation coalitions, which involve actors across the walls and ceilings of the health care 
system. The last approach underlines the multilevel character of health care innovation.  
 
 
Evidence-based change. After years of advocacy and evaluation research, ideas about 
evidence-based medicine (Sackett  1997) are beginning to take root in health care. Not so 
much as a common practice, but as a direction for health care-development in the near future. 
The same logic of using scientific data as much as possible to direct medical practice seems to 
apply to innovations at the service and system level. It is all too clear that many measures 
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don’t have the long-term effects they were designed for. We are discovering, for example 
(Porter and Olmsted Teisberg 2004) that new incentives to reduce costs, in fact make costs 
rise. To date we lack the access to information about these effects. The walls and ceilings play 
an important role in this respect. Policy-makers, managers, professionals are in an urgent need 
of information about the effects of new treatment strategies and new organizational processes 
in which they are embedded (Haines and Iliffe 1995, Porter and Olmsted Teisberg 2004). 
Furthermore, they need the same kind of information to monitor change processes in their 
own organizations. As one our interviewees, psychiatrist and general director of a psychiatric 
hospital formulated: “You don’t have a change process without measuring change. Without 
measurement it is all fake.”  
 
The innovative coalition. The diffusion study of Denis et al. (2002) indicates that the 
pace of diffusion is accelerated when there is a strong pro-innovation coalition. That means 
that different stakeholders (managers, clinicians, patients, insurers) share benefits and risks. 
Other studies (Adolfini 2003, Lemieux-Charles et al. 2002, Striem et al. 2003) stress that the 
shared responsibility and involvement of both management and clinicians is crucial for 
effective implementation. Otherwise the risk arises (Adolfini 2003) that improvement policies 
become separated from practice. In other words (Striem et al. 2003): the ownership of change 
has to be shared between clinicians and administrators at all levels and functions of the 
system. The focused factories in our field study were built by strong cross-functional teams, 
with many physicians among the helmsmen. It might be expected that the role of the patients, 
family and volunteer aid also changes in this development: from receiver to co-developer.  
 
 Multilevel change. Primarily, the analysis above focuses on the boundaries (or 
“ceilings”) between the echelons of health care. That doesn’t mean that good examples of 
cross-level innovation cannot be found. A good example (Lemieux and Blidner 2002) is the 
regional experiment with the Coordinated Stroke Strategy (CSS) in Canada. This pilot study 
in four regions was initiated by The Heart and Stroke foundation in Ontario, a voluntary 
research and grant body. The Ministry of Health funded the project, while a professional 
dissemination network had been instrumental in the diffusion and implementation of the new 
approach for the treatment of acute strokes. Actors at the different levels played different 
roles. The advocacy organization was the initiator and invested resources for dissemination 
and implementation of CSS. The necessary structural changes to stroke care, and the clinical 
and system changes could not be sustained without provincial government support. The 
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diffusion of CSS would also not have been possible without intensive cooperation between 
various health care services. Service management played an important role in realizing that 
cooperation. Functional leadership, and their professional associations had a role in shaping 
the clinical content of the program, and clinical staff had to be prepared for the new practice. 
One might argue that diffusion of health care innovations requires multiple level- and cross 
level-decision making embedded in a collective organizational context. Grass root innovation 
has little chance without support from senior management (Savits et al. 2000). At the same 
time it has been made clear (Striem et al 2003) that broader change programs without 
commitment of the professionals don’t make sense either. 
 
Best practice examples, like the ones described in the study of Schrijvers et al. (2002) 
are very useful in showing that alternatives for malfunctioning practice do exist. However, 
they have a limited value for guiding wide scale implementation. Our study indicates that 
wide scale implementation of better practice requires a deep understanding of the horizontal 
and vertical dimensions of the innovation process.  
 
 
8. Conclusions 
 
Service innovation is a field of growing interest for innovation researchers. However, 
the research is still in its infancy.  Pioneers in the field of service innovation research 
(Coombs 2004, Miles 2004, Tether and Metcalfe 2003) have pointed at the limited value of 
concepts, models, and typologies from the manufacturing industry for understanding 
innovation in the service sector. It is argued in this paper, that the same holds for the research 
into innovation in health care services. In this domain our knowledge is still fragmented, and 
we lack common frameworks, like for example Pavitt’s (1984) well-know sectoral taxonomy, 
and Cooper’s (1994) stage-gate models. Our research practice in two EU-funded network 
programs (Publin and INNOFLEX) indicated that such conceptual instruments are of great 
use in the comparison and integration of studies from various contexts.  
 
The huge pressure to reform the health care industry creates a strong need for 
knowledge that supports that change. Health care innovation tends to be a complex of 
interrelated functional (or: clinical), process improvements and systemic changes. In this 
development, diffusion and implementation appear to be the vulnerable phases. This paper, 
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based on a literature survey and an explorative study, has aimed to contribute to the 
understanding of the forces that drive and block the development, implementation and 
diffusion of health care innovation. For this purpose a two dimensional framework has been 
presented, which makes it possible to “map” the innovation and its development process 
within the wider context of health services, health processes and health systems. Considering 
the early development stage of health innovation studies, the mapping metaphor (Christensen 
2000) seemed more appropriate than a static taxonomy.  
  
This exploratory study indicates that future researchers should be aware of the 
multilevel character of health care innovation. Cross-level cooperation appears to be crucial in 
realizing the full potential value of new techniques, technologies, processes and systems. For 
that purpose (Denis et al. 2002) an insight in the distribution of benefits and risks originating 
from the new practice is needed. Furthermore this study hopes to encourage innovators, either 
working at the grassroots or at policy level, to invest in building pro-innovation coalitions, 
which base their cooperation on evidence of patient- and service outcomes. Finally, it has to 
be stressed that innovation in health care is basically a process of organizational and inter-
organizational learning.  The creation of new structures for disseminating evidence appears to 
be an insufficient condition for its dissemination. It is essential (cf. Lemieux-Charles et al. 
2003) that settings are created in which professionals, managers and policy-makers join to 
develop collective knowledge.  
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